{"id":614601,"title":"Notice to stakeholders: Release of guidance document: Information and submission requirements for biosimilar biologic drugs for the addition of an indication where there is no/minimal data required to accompany the submission - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T02:50:44.250000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/notice-stakeholders-guidance-biosimilar-biologic-drugs-submission-requirements-no-minimal-data.html","snippet":"Notice to stakeholders: Release of guidance document: Information and submission requirements for biosimilar biologic drugs for the addition of an indication where there is no/minimal data required to accompany the submission Health Canada (HC) is pleased to announce the release…","rawSnapshotUrl":"/api/snapshots/raw/614601","browseUrl":"https://replay.healtharchive.ca/job-6/20260302025044/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/notice-stakeholders-guidance-biosimilar-biologic-drugs-submission-requirements-no-minimal-data.html#ha_snapshot=614601","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}